XIX GEIS International Symposium

-

-

-

-

-

-

-

-

Format: online.

Dates:   October 14th and 16th, 2021

-

Thursday, October 14th:

15:20-15:30 Welcome & Introduction. José M. Asencio, Claudia Valverde


15:30-16:30 SESSION 1. FOCUSING ON LOCAL THERAPY
Chairs:        José M. Asencio, Hospital General Univ. Gregorio Marañón,
                  Raquel Correa, Hospital Univ. Virgen de la Victoria, Málaga


15:30-15:45 Plastic surgery in STS surgery: When can we help you?
                  Iván Monge, Hospital Universitario Son Espases, Palma de Mallorca

15:45-16:00 Updates in bone sarcoma surgery. Has functionality improved in the last decade?
                  Isidro Gracia, Hospital de la Santa Creui i Sant Pau, Barcelona

16:00-16:15 Radiotherapy in localized STS Pre or post? Pros and Cons and other controversies.
                  Peter Chung, Princess Margaret Cancer Center, Toronto (Ontario), Canada

16:15-16:30 Surgery in relapsed retroperitoneal sarcomas how to deal with it?
                  Chandrajit P. Raut, Dana Farber Cancer Institute, Boston (Massachusets), USA

16:30-16:45 Discussion

16:45-16:50 Coffee break

16:50-18:05 SESSION 2 LET’S IMPROVE. ADVANCES IN SYSTEMIC THERAPY
Chairs:        Soledad Gallego, Nadia Hindi

16:50-17:05 What have we learnt in Ewing sarcoma in the last years? Current standards in upfront and  
                  further lines
.
                  Martin McCabe University of Manchester, United Kingdom

17:05-17:20 News in Immunotherapy.
                  TBC

17:20-17:35 News in GIST therapy
                  Sebastian Bauer, Essen University Hospital, Essen, Germany

17:35-17:50 New targeted therapy opportunities in sarcoma.
                  Shreyas Patel, MD Anderson Cancer Center, Houston (Texas), USA


17:50-18:05 Discussion

18:05-18:10 5-minute Pause


18:10-18:55 SESSION 3. SARCOMA SUBTYPE HIGHLIGHTED: SYNOVIAL SARCOMA
Chairs:        Javier Martín Broto,
                  Cleofé Romagosa, Hospital Univ. Vall d'Hebron, Barcelona

18:10-18:25 Pathologic insights.
                  Cristina Antonescu MSKCC, New York

18:25-18:40 Treatment opportunities.
                  William Tap, Memorial Sloan Kettering Cancer Center, New York (New York), USA

18:40-18:55 Discussion


18:55-19:00 Last Pull Break


19:00-20:00 SESSION 4. CHALLENGING ISSUES
Chairs:        Rosa Álvarez, Hospital General Univ. Gregorio Marañón, Madrid,
                  Fina Cruz, Hospital Universitario de Canarias, Tenerife

19:00-19:15 How can molecular biology help us in the daily clinic?
                  Ana Vivancos, Vall d'Hebrón University Hospital, Barcelona

19:15-19:30 What can an interventional Radiologist offer to sarcoma therapy?
                  Daniel Bernabeu, Hospital Universitario La Paz, Madrid

19:30-19:45 Management of intermediate aggressiveness entities (TCG bone and soft part) how to
                  integrate targeted therapies.

                  Silvia Stacchiotti, Istituto Nazionale dei Tumori, Milan, Italy

19:45-20:00 Discussion

20:00-20:05 Farewell
                  Claudia Valverde, Hospital Univ. Vall d'Hebron, Barcelona

 

Friday, October 15th:

16:00-17:00 Executive Meeting (Closed meeting)

17:30-19:30 GEIS General Assembly (members only)

Saturday, October 16th:

09:00-10:30 Patients' Satellite Symposium (in Spanish)
                  César Serrano, Javier Martínez Trufero, Ana Sebio, Javier Lavernia.

-

-

-Language:

Lectures will be delivered in English or Spanish. Simultaneous translation will be available on October, 14th.

-

Registrations:

Registration fees:

  • Up to September, 15th:     400€ Spanish VAT included
  • After September, 15th:      550€ Spanish VAT included

.

Method of Payment:

By bank transfer:

Bank account holder: Grupo Español de Investigación en Sarcomas
IBAN:                       CAIXABANK ES22 2100 0827 10 0200642611

-

Symposium Secretariat:

Grupo Español de Investigación en Sarcomas (GEIS)
E-mail: eventos(at)grupogeis.org
Tel.: (+34) 912 866 807

 
GEIS Symposium 21 UNDER THE AUSPICES OF 1as
 
 
Patients Associations
 
 

Sponsors

Major Sponsors:

pharmasimpv2

pfizerv2

 
 
 
 
 

Other Sponsors:

bayer

karyopharm

 
 
 
 
 

Minor Sponsors:

Blueprint Logo RGB full colorv2

eisaiv2

gsk logo